Cerus Corporation (CERS)
Cerus Corporation - DRK Blood Donation ServiceBaden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated withCerus’ INTERCEPT™ Blood System in Routine Clinical Practice
Cerus Corporation - DRK Blood Donation ServiceBaden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated withCerus’ INTERCEPT™ Blood System in Routine Clinical Practice
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak financial signals • Minimal market impact expected **Sentiment:** Neutral (50%) **Content type:** Financial